Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
about
Caspase 8 polymorphisms contribute to the prognosis of advanced lung adenocarcinoma patients after platinum-based chemotherapy.Racial disparity in metabolic regulation of cancer.miRNAs associated with the malignant transformation of non-small cell lung cancer.Are there any differences in genomic characterization of non-small cell lung cancer between African Americans and Whites?Clinical implications of genetic heterogeneity in multifocal pulmonary adenocarcinomasPrevalence of EGFR Mutations in Lung Cancer in Uruguayan Population.The safety of afatinib for the treatment of non-small cell lung cancer.Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?Brief Report: Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients.Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians.Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients.Racial Disparities in the Molecular Landscape of Cancer.Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.
P2860
Q33439990-9EB44189-2D47-4632-AA86-A92D18839A1EQ33906704-12071AFC-D3DE-44A3-A285-5F3D8EE1490DQ36949599-21B266D5-D93D-4891-B312-E0DD995C1FECQ37528277-A5A4F306-377F-47C8-9360-C73F1A343C96Q37581276-30407432-418F-4B51-9A15-86624C88DF70Q38661269-86F14952-4494-4268-9D2A-A6AB1EE45762Q38955468-DDC3E055-3682-4526-8D7F-1287686BFE66Q38995524-A415C5F5-C3F5-44DB-BA62-8FE0431F3F5BQ39441334-AC41D213-737B-440D-9460-9F6144880909Q40040415-3D2AD9B5-E1F9-4D51-93C8-8F54C9FCF898Q41612456-7308E9B5-C5C9-4053-8FEE-5970BAECA8A0Q47097853-401B0560-0E01-4DF8-BF63-896977401C48Q52723102-1C835B8C-E47B-4C0D-8809-6B9B554CE758Q54967623-6E8F18BD-3244-400A-9AC7-143FDF568592
P2860
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of race in oncogenic driv ...... ng Cancer Mutation Consortium.
@en
Role of race in oncogenic driv ...... ng Cancer Mutation Consortium.
@nl
type
label
Role of race in oncogenic driv ...... ng Cancer Mutation Consortium.
@en
Role of race in oncogenic driv ...... ng Cancer Mutation Consortium.
@nl
prefLabel
Role of race in oncogenic driv ...... ng Cancer Mutation Consortium.
@en
Role of race in oncogenic driv ...... ng Cancer Mutation Consortium.
@nl
P2093
P2860
P356
P1433
P1476
Role of race in oncogenic driv ...... ng Cancer Mutation Consortium.
@en
P2093
Bruce E Johnson
Conor E Steuer
Edward B Garon
Fadlo R Khuri
Gabriel Sica
Lynne Berry
Madhusmita Behera
Michael Rossi
Paul A Bunn
Sungjin Kim
P2860
P304
P356
10.1002/CNCR.29812
P407
P50
P577
2015-12-22T00:00:00Z